chronic fatigue syndrome | GenomeWeb

chronic fatigue syndrome

Mass spec-based analysis of CFS patients shows an analyte signature indicative of a stalled, underperforming metabolism, and could help diagnose the condition.

The independent panel called for steps to address shortcomings in research and gaps in knowledge about myalgic encephalomyelitis/chronic fatigue syndrome.

NEW YORK (GenomeWeb) – Scientists at Nova Southeastern University's Institute for Neuro-Immune Medicine will use a $2 million grant from the National Institute of Neurological Disorders and Stroke to study complex biomarkers of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in men, N

NEW YORK (GenomeWeb) — The Open Medicine Institute said last week that it will use Affymetrix expression microarrays to develop tests to diagnose and aid in the treatment of myalgic encephalomyelitis and chronic fatigue syndrome.

NEW YORK (GenomeWeb News) – The Open Medicine Institute of Mountain View, Calif., will use a $1 million foundation award to fund a study aimed at uncovering the role of genetics and heritable risk in myalgic encephalomyelitis/chronic fatigue syndrome.

NEW YORK (GenomeWeb News) – JPT Peptide Technologies and The Institute for Medical Immunology at the Charite in Berlin announced on Wednesday an agreement to develop serological peptide biomarkers for the differential diagnosis of chronic fatigue syndrome.

NAME: John Hackett, Jr.
POSITION: Volwiler research fellow and manager, emerging pathogens and virus discovery, Abbott Diagnostics

Two recently published studies suggest that laboratory contamination was the likely cause of previous evidence linking murine viruses to CFS, highlighting the fact that researchers conducting PCR experiments should be extremely cautious about both inherently contaminated commercial reagents and contamination from laboratory manipulation.

Chronix is developing a test based on its circulating DNA detection technology that will be tested in studies of how patients respond to Hemispherx's experimental drug Ampligen.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.